Apert Syndrome is a rare congenital disorder that profoundly affects skull and limb development. It results from the premature fusion of specific skull bones, a condition known as craniosynostosis, and the fusion of fingers and toes (syndactyly). These features cause distinctive craniofacial appearances and hand or foot abnormalities. Although uncommon, Apert Syndrome remains an important condition in pediatric genetics due to its significant physical, functional, and psychosocial implications. 

First described in 1906 by French physician Eugène Apert, this syndrome belongs to a group of disorders called acrocephalosyndactyly syndromes. Effective care for Apert Syndrome requires collaboration across multiple specialties, including genetics, craniofacial surgery, orthopedics, neurosurgery, and developmental therapy. This article provides a comprehensive overview of Apert Syndrome—covering its causes, genetic mechanisms, pathophysiology, clinical presentation, diagnosis, management, prognosis, and preventive considerations. 

Apert Syndrome is a genetic craniofacial disorder marked by early closure of the coronal sutures in the skull, resulting in an abnormal skull shape and restricted brain growth. The condition also causes fusion of digits (syndactyly) and distinct facial features such as a high forehead and underdeveloped midface. 

Key characteristics include: 

• Craniosynostosis: premature fusion of skull sutures, leading to increased intracranial pressure. 

• Syndactyly: fusion of the fingers and toes, often complex and symmetrical. 

• Facial abnormalities: including shallow eye sockets, flat midface, and prominent eyes (proptosis). 

Apert Syndrome is part of the FGFR-related craniosynostosis syndromes, which also include Crouzon, Pfeiffer, and Jackson-Weiss syndromes. Among these, Apert is unique for its severe hand and foot fusion. The condition affects both sexes equally and occurs in about 1 in 65,000 to 88,000 live births worldwide. 

The root cause of Apert Syndrome is a mutation in the FGFR2 gene (fibroblast growth factor receptor 2) located on chromosome 10q26. This gene plays a crucial role in cell growth and bone formation. Mutations in FGFR2 result in abnormal signaling that leads to premature bone fusion. 

Common mutations 

• Ser252Trp (S252W) – responsible for approximately 67% of cases. 

• Pro253Arg (P253R) – accounts for roughly 31% of cases. 

These mutations cause gain-of-function effects, resulting in excessive FGFR2 activity and abnormal bone differentiation. 

Inheritance pattern 

Apert Syndrome follows an autosomal dominant inheritance pattern. However, most cases occur due to de novo mutations (new mutations not inherited from either parent), which are often linked to advanced paternal age. If a parent is affected, there is a 50% chance of passing the condition to each child. 

Key risk factors: 

• Advanced paternal age 

• Family history of FGFR2 mutation (rare) 

• De novo mutation during conception 

Genetic counseling is essential for affected families to understand recurrence risks and prenatal diagnostic options. 

In Apert Syndrome, the FGFR2 mutation leads to abnormal bone development by overstimulating osteoblasts (bone-forming cells). This overactivity causes early closure of cranial sutures, limiting skull growth and forcing compensatory expansion in other directions. The result is a short, high skull (acrobrachycephaly) or a tower-shaped skull (turribrachycephaly). 

Key pathophysiologic processes: 

• Premature ossification of cranial sutures restricts skull expansion. 

• Intracranial hypertension can develop due to limited brain space. 

• Midfacial hypoplasia leads to shallow orbits, causing eye protrusion (proptosis) and breathing difficulties. 

• Complex syndactyly results from abnormal differentiation of soft tissue and bone in the hands and feet. 

These abnormalities combine to create both cosmetic and functional challenges, emphasizing the need for early, coordinated treatment. 

Apert Syndrome is rare, affecting approximately 1 in 65,000 to 88,000 live births. It occurs equally in males and females and has been reported across all ethnic and geographic populations. Most cases arise sporadically rather than through inheritance. Although rare, its impact on quality of life and the intensity of required care make early diagnosis crucial. 

The clinical presentation varies widely, but most individuals exhibit characteristic features affecting the head, face, limbs, and other systems. 

Craniofacial features 

• Tall, tower-shaped skull (acrobrachycephaly) 

• Bilateral coronal craniosynostosis 

• Flat midface (midfacial hypoplasia) 

• Prominent, wide-set eyes (proptosis, hypertelorism) 

• Depressed nasal bridge with a beaked nose 

• High-arched or cleft palate 

• Dental crowding and malocclusion 

• Conductive hearing loss from frequent ear infections 

Limb features 

• Complex syndactyly (fusion of the second, third, and fourth fingers) 

• Broad or deviated thumbs 

• Fusion of toes, with a broad, medially deviated big toe 

Neurological and developmental features 

• Mild to moderate intellectual disability (some may have normal intelligence) 

• Hydrocephalus due to venous congestion or aqueductal stenosis 

• Possible seizures 

Other associated findings 

• Respiratory problems due to airway narrowing 

• Obstructive or central sleep apnea 

• Gastroesophageal reflux 

• Occasional heart defects (e.g., ventricular septal defect) 

These features underline the complex, multisystem nature of Apert Syndrome, necessitating a comprehensive and long-term care strategy. 

Diagnosis typically begins with recognizing characteristic facial and limb abnormalities. It may also be suspected before birth via prenatal imaging. 

Clinical evaluation 

• Observation of craniosynostosis, facial features, and syndactyly 

• Prenatal ultrasound showing abnormal skull shape and fused digits 

Genetic testing 

Definitive diagnosis is confirmed through FGFR2 mutation analysis using: 

• Peripheral blood (postnatal) 

• Amniotic fluid or chorionic villus sampling (prenatal) 

Imaging studies 

• CT or MRI scans to identify fused cranial sutures and assess brain structure 

• X-rays of hands and feet to document bony fusion 

• Brain imaging to detect hydrocephalus or Chiari malformation 

Additional evaluations 

• Hearing assessments 

• Eye exams for strabismus or corneal exposure 

• Developmental and cognitive assessments 

• Sleep studies to evaluate for apnea 

Early and accurate diagnosis enables timely surgical planning and developmental intervention. 

Several syndromes can resemble Apert Syndrome but differ in key clinical or genetic aspects: 

• Crouzon Syndrome: craniosynostosis without syndactyly 

• Pfeiffer Syndrome: broad thumbs and big toes with mild syndactyly 

• Carpenter Syndrome: craniosynostosis with extra digits (polysyndactyly) 

• Saethre-Chotzen Syndrome: mild craniosynostosis with low-set hairline 

• Muenke Syndrome: isolated coronal synostosis 

• Antley-Bixler Syndrome: craniosynostosis with joint and skeletal anomalies 

Molecular testing for FGFR2 and related genes helps distinguish among these conditions and guide family counseling. 

Multidisciplinary care 

Optimal management requires collaboration among specialists in craniofacial surgery, neurosurgery, genetics, ENT, ophthalmology, orthopedics, and psychology. Treatment is individualized and staged over time. 

Surgical management 

Cranial vault surgery 

Performed in infancy (around 6–12 months) to: 

• Relieve intracranial pressure 

• Improve skull shape and allow brain growth 

• Reduce risk of vision and developmental complications 

Midface advancement (Le Fort III osteotomy) 

Typically performed between 6–12 years of age to: 

• Correct midfacial hypoplasia 

• Improve breathing and dental occlusion 

Syndactyly release surgery 

Usually performed in stages, starting at 1–2 years of age to: 

• Separate fused fingers 

• Enhance hand function and appearance 

Supportive and rehabilitative care 

• Airway management: CPAP, adenotonsillectomy, or midface advancement for severe apnea 

• Hearing care: tympanostomy tubes and routine hearing checks 

• Ophthalmologic care: lubrication and strabismus correction to protect vision 

• Orthodontic care: management of dental crowding and bite alignment 

• Developmental therapy: early intervention for speech, motor, and cognitive skills 

• Psychological support: addressing body image, self-esteem, and family coping 

• Genetic counseling: recurrence risk and reproductive planning for families 

Untreated or severe cases may result in: 

• Elevated intracranial pressure and hydrocephalus 

• Breathing difficulties and sleep apnea 

• Vision loss from corneal damage 

• Recurrent ear infections and hearing impairment 

• Developmental delays or learning difficulties 

• Emotional and psychosocial stress due to facial differences 

• Surgical risks such as infection or scarring 

Ongoing follow-up helps identify and manage these complications early. 

The outlook varies depending on the severity of cranial and facial abnormalities, the presence of associated anomalies, and the timeliness of treatment. With comprehensive multidisciplinary care, most individuals achieve improved cranial shape, hand function, and quality of life. Many children attend mainstream schools and lead fulfilling lives with appropriate medical and social support. 

Positive outcomes are closely linked to early surgical intervention, ongoing developmental therapies, and family engagement in care. 

Since most cases are caused by spontaneous FGFR2 mutations, complete prevention is not possible. However, several strategies can support early identification and informed decision-making: 

• Genetic counseling for families with an affected child 

• Prenatal screening through ultrasound and FGFR2 testing 

• Awareness of paternal age effects in family planning 

These measures help families prepare for early treatment and ensure that affected infants receive timely, specialized care. 

Living with Apert Syndrome involves managing both physical and emotional challenges. Early interventions, surgical corrections, and continuous therapy can help maximize independence and improve quality of life. 

Supportive approaches 

• Regular follow-up with craniofacial and developmental teams 

• Access to occupational, speech, and physical therapy 

• Support groups and counseling for families 

• Educational accommodations for learning differences 

Community and peer support play vital roles in helping families navigate the lifelong journey of Apert Syndrome. 

Apert Syndrome is a complex congenital disorder requiring early recognition and coordinated multidisciplinary care. Advances in genetics, craniofacial surgery, and supportive therapies have significantly improved outcomes and quality of life for affected individuals. Early surgical intervention, developmental support, and family-centered care are the cornerstones of management. 

Future research exploring FGFR2-targeted therapies and innovative surgical techniques holds promise for further improving outcomes. Holistic support—addressing medical, developmental, and psychosocial needs—remains essential to helping individuals with Apert Syndrome thrive. 

1. Cohen MM Jr, Kreiborg S. Apert syndrome: a clinical review. J Craniofac Genet Dev Biol. 1993;13(2):105-126. 

2. Wilkie AO, Morriss-Kay GM. Genetics of craniofacial development and malformation. Nat Rev Genet. 2001;2(6):458-468. 

3. Kimonis VE, Gold JA, Hoffman TL, Panchal J, Boyadjiev SA. Genetics of craniosynostosis. Semin Pediatr Neurol. 2007;14(3):150-161. 

4. Park DH, Kim ES, Nam SH, et al. Apert syndrome: clinical and genetic aspects. Arch Plast Surg. 2015;42(5):573-579. 

5. Persing JA. Management considerations in the treatment of craniosynostosis. Plast Reconstr Surg. 2008;121(4 Suppl):1-11.